In a previous issue of Critical Care, Filseth and colleagues [1] describe the cardiovascular eff ects of surface cooling towards severe hypothermia (25°C) and subsequent surface re-warming in an anesthetized, closed-chest pig model, focusing particularly on post-hypothermic ventricular function.
In a previous issue of Critical Care, Filseth and colleagues [1] describe the cardiovascular eff ects of surface cooling towards severe hypothermia (25°C) and subsequent surface re-warming in an anesthetized, closed-chest pig model, focusing particularly on post-hypothermic ventricular function.
Hypothermia may improve outcome after an ischemic event. Remarkable, anecdotal examples of this phenomenon are known from skiing accidents, winter warfare and other cold, human pastimes. In medicine, intentional use of controlled hypothermia has a long history. Presumably, the most widely used and accepted therapeutic applications are cooling to enable procedures with prolonged ischemia, such as open heart surgery, organ preservation and transplantation. In planned surgery, hypothermia is typically induced as a protective strategy before the start of ischemia. Currently, however, the effi cacy of hypothermia as an emergency treatment during ongoing ischemia or reperfusion in cases such as stroke, myocardial infarction, and cardiac arrest is receiving much attention. Randomized clinical trials have demonstrated that treatment with moderate hypothermia improves survival and neurological outcome in unconscious patients after resuscitation from out-ofhospital cardiac arrest [2, 3] . As a result, recent American and European guidelines recommend the induction of therapeutic hypothermia for comatose cardiac arrest survivors [4, 5] . Research has importantly focused on hypothermia as a neuroprotective strategy and a wide range of pathways that might be involved in the benefi cial eff ects of cooling has been described. Th e basic theory is that hypothermia slows down cellular metabolism and oxygen demand and thereby reduces the harmful acute and delayed eff ects of oxygen deprivation. Hypothermia attenuates ischemia-induced free radical production, and abnormalities in cellular calcium handling and pH balance [6] . Furthermore, hypothermia may target more delayed cell death processes by aff ecting infl ammatory signaling and apoptotic pathways [7] . In principle, these protective mechanisms apply not only to the brain but also to the heart (and other organs, for that matter). However, in contrast to rather convincing animal data [8] , clinical studies aiming to determine whether hypothermia limited infarct size in patients with ST segment elevation myocardial infarction (STEMI) under going percutaneous revascularization [9] or in survivors of cardiac arrest [10] did not clearly establish such an eff ect.
In addition to the pursued protective eff ects, hypothermia induces important physiological changes, or side eff ects, in almost every organ system. Th ese changes partly result from physiological thermoregulatory refl exes aimed at decreasing heat loss and restoring normal temperature, such as sympathetic activation, cutaneous vasoconstriction, and shivering. More generally, enzyme kinetics are temperature-dependent and thus, in principle, all enzyme-mediated reactions, including drug metabolism, are aff ected by hypothermia. Th e direct eff ect of temperature per se on myocardial function has been the subject of various previous studies. Basic in vitro studies in muscle strips from healthy myocardium have shown substantially increased contractility (measured as Abstract This commentary discusses a paper by Filseth and colleagues in a previous issue of Critical Care. The authors describe the cardiovascular eff ects of induced hypothermia, focusing particularly on posthypothermic ventricular function. The fi ndings indicate that the treatment resulted in reduced systolic but unchanged diastolic left ventricular function with compensatory eff ects on heart rate and systemic vascular resistance. The novel aspects of this study are the registration of ventricular function using sophisticated, load-independent indices in a clinically relevant, large animal model during the entire cooling and re-warming trajectory of hypothermia therapy.
isometric twitch force) and prolonged contraction and relaxation times with mild hypothermia [11] . Recently, studies in isolated failing human myocardium have shown very similar results [12] . Despite a prolonged action potential, these eff ects seem not to be associated with increased sarcoplasmatic reticulum calcium content or altered calcium transients, suggesting that increased calcium responsiveness of the myofi laments is the main mechanism for the observed increased inotropism. Consistent with these fi ndings, intact animal studies with mild hypothermia have shown increased systolic function, resulting in increased cardiac output despite reduced heart rate, whereas vascular resistance was generally reported to be relatively unaff ected [11] . In contrast, however, in some clinical studies increased vascular resistance was reported to dominate and lead to a reduced cardiac output [3] . Diff erences between species and anesthesia-analgesia protocols may explain variable fi ndings [13] . Based upon the increased myofi lament calcium sensitivity, impaired diastolic function may ensue. Th is is indeed confi rmed in a recent study that carefully examined the eff ects of hypothermia on diastolic function in an intact pig model showing a delayed and prolonged active relaxation and a decreased diastolic distensibility. Although the reduced heart rate could be expected to compensate and improve diastolic fi lling, this is generally not the case because hypothermiainduced heart rate reduction results almost entirely from a prolonged contraction whereas the diastolic interval is virtually unchanged [14] .
Th e complex interplay between intrinsic biophysical and biochemical eff ects and compensatory physiological changes combined with potentially altered drug responses complicates the management of patients subjected to induced hypothermia in the intensive care unit [15] . Th e paper by Filseth and colleagues adds new information by reporting on left ventricular function not only during induction of hypothermia, but also during the re-warming and, particularly, the post-hypothermic stage. Th e fi ndings during mild hypothermia (34°C) largely confi rm previous reports with improved systolic function and depressed diastolic function. However, the authors continued cooling to 25°C. During induction of severe hypothermia, diastolic function gradually decreased further, but systolic function also started to decrease at this stage. During re-warming, most indices tended to return to baseline values. However, post-hypothermic systolic function remained depressed in contrast to diastolic function, which fully normalized.
Th e authors are to be complimented for developing an animal model that closely mimics human physiology and by using advanced invasive pressure-volume methods to assess cardiac function. Th e main conclusions of the paper relate to post-hypothermic circulatory and ventricular function. When trying to translate these fi ndings to the clinical situation, several potential limitations of the study should be mentioned. First, the study was performed in normal, healthy pigs and the direct eff ects and late consequences of hypothermia may be diff erent in, for example, elderly subjects with depressed left ventricular function. Second, the authors induced severe hypothermia in contrast to mild hypothermia recommended by current guidelines. Th ird, steady state hypothermia was maintained for only 1 hour, which is very diff erent from, for example, the 12 to 24 hours recommended for comatose post-cardiac arrest patients. Th us, the study clearly provides interesting new data on the eff ect of temperature on intrinsic ventricular function in a clinically relevant animal model. However, the translation of the fi ndings to post-hypothermic critical care patients warrants further studies.
